Wire Stories
Dr. Reddy�s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB (celecoxib oral solution) 25 mg/mL
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy�s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter known as �Dr. Reddy�s�),...